Pharma Walks Out, Red Tape Gone Mad, Oracle Skyrockets
Join Neil Woodford and Jon Adair as they discuss the week’s most significant market stories. In this episode, Neil shares his insights on Merck’s decision to halt its billion-pound research centre in London, central bank rate decisions, China’s latest stimulus measures, and Larry Ellison’s unprecedented wealth gain. Discover why bond yields are returning to previous levels and what this means for investors.
Join Neil Woodford and Jon Adair as they discuss the week’s most significant market stories. In this episode, Neil shares his insights on Merck’s decision to halt its billion-pound research centre in London, central bank rate decisions, China’s latest stimulus measures, and Larry Ellison’s unprecedented wealth gain. Discover why bond yields are returning to previous levels and what this means for investors.
Subscribe to W4.0 for more in-depth financial discussions and insights. If you’re a W4.0 member, send in your questions for next week’s episode!
🔗 Read more on W4.0: https://www.w4pz.com
Join Neil Woodford and Jon Adair as they discuss the week’s most significant market stories. In this episode, Neil shares his insights on Merck’s decision to halt its billion-pound research centre in London, central bank rate decisions, China’s latest stimulus measures, and Larry Ellison’s unprecedented wealth gain. Discover why bond yields are returning to previous levels and what this means for investors.
Subscribe to W4.0 for more in-depth financial discussions and insights. If you’re a W4.0 member, send in your questions for next week’s episode!
🔗 Read more on W4.0: https://www.w4pz.com